Top Ad
Orlistat Capsule

Orlistat Capsule

Form: Capsules

Strength: 120 mg; Alli(60 mg)

Reference Brands: Xenical(US & EU)

Category: Weight Loss drugs

Orlistat capsules, marketed as Xenical (prescription) and Alli (OTC), are approved in the US by the FDA and in the EU via EMA for weight management and obesity. Regulatory approval requires dossiers including safety assessments, clinical efficacy, manufacturing standards, and pharmacovigilance plans. The FDA reviews clinical trial and quality data for effective approval, while the EMA ensures compliance with regional safety and manufacturing regulations. For dossier preparation, regulatory pathways, and market access guidance, visit PharmaTradz. Proper regional adherence supports timely approval, safe use, and global availability, helping consumers worldwide achieve weight loss through effective dietary fat-blocking therapy supported by regional regulations.

Get Enquiry Back to Listing
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.

Related Products

Metreleptin Injectable Solution

Strength: 11.3 mg/vial

Form: Injectable Solution

Reference Brands: Myalept(US & EU)

View Details Get Enquiry
setmelanotide Injectable solution

Strength: 4 mg/mL

Form: Injectable Solution

Reference Brands: Imcivree(Us & EU)

View Details Get Enquiry
naltrexone hydrochloride + bupropion hydrochloride ER tablets

Strength: 8 mg naltrexone hydrochloride / 90 mg bupropion hydrochloride

Form: ER tablets

Reference Brands: Contrave(US & EU)

View Details Get Enquiry
Phentermine/Topiramate Extended-Release Capsules

Strength: 3.75 mg/23 mg, 7.5 mg/46 mg, and 15 mg/92 mg

Form: Capsules

Reference Brands: Qsymia(US & EU)

View Details Get Enquiry

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.